Seelos Therapeutics Releases the Itinerary for its Research and Development Update Conference Call and Webcast to be Held on December 15, 2022 Psychedelics Investing
COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP Psychedelics Investing
Goodness Growth Holdings Celebrates the Life and Legacy of Dr. Jay Westwater with Special Event Psychedelics Investing
BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology in Phoenix, Arizona Pharmaceutical Investing
Lobe Sciences Provides an Update to Clinical Development Plans for Its Proprietary Psilocin Product, L-130 Pharmaceutical Investing
COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference Psychedelics Investing
